Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The prognostic impact of mutations in spliceosomal genes for myelodysplastic syndrome patients without ring sideroblasts

Fig. 2

Clinical outcomes are affected by the mutation status of spliceosomal genes. Kaplan-Meier analysis of overall survival ac, progression-free survival df, and probability of AML transformation gi for the total MDS patient cohort (n = 129), stratified according to SF3B1, U2AF1, and SRSF2 mutation status. AML, acute myeloid leukemia; wt, wild-type; mut, mutant

Back to article page